Medifast, Inc. MED is behind one of the fastest-growing health and wellness communities, OPTAVIA, that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on MED’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Medifastcould be a solid choice for investors.
Current Quarter Estimates for MED
In the past 30 days, one estimate has gone higher for Medifastwhile none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from $1.18 a share 30 days ago, to $1.84 today, a move of 55.9%.
Current Year Estimates for MED
Meanwhile, Medifast’s current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $5.40 per share 30 days ago to $6.95 per share today, an increase of 28.7%.
MEDIFAST INC Price and Consensus
MEDIFAST INC price-consensus-chart | MEDIFAST INC Quote
The stock has also started to move higher lately, adding 40.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So, investors may want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MEDIFAST INC (MED) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research